Karyopharm Therapeutics Inc (KPTI) Shares Up Despite Recent Market Volatility

12d ago, source: newsheater

Based on Karyopharm Therapeutics Inc (KPTI), the company’s capital structure generated 4.58 points at debt to capital in total, while cash flow to debt ratio is standing at -0.53. The debt to equity ...

Karyopharm Therapeutics Inc KPTI

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23d ago, source: Yahoo Finance

NEWTON, Mass., April 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the ...

Karyopharm Therapeutics: Q4 Earnings Snapshot

1mon ago, source: SFGate

NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $41.8 million in its fourth quarter. On a per-share basis, the Newton ...

INESSS Recommendation to Deny Reimbursement for Multiple Myeloma Treatment is a Global Outlier

3h ago, source:

FORUS Therapeutics Inc. ("FORUS") is deeply disappointed and disagrees with the recent decision by the Honourable Christian ...

ATXS Astria Therapeutics, Inc.

1d ago, source: Seeking Alpha

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Karyopharm Therapeutics Inc KPTI

21d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Karyopharm Therapeutics Inc (KPTI)

19d ago, source: Investing

Karyopharm Therapeutics (NASDAQ:KPTI) has conducted its Fourth Quarter and Full Year 2023 Financial Results Conference Call, highlighting its financial status and progress in ...

Karyopharm Therapeutics Inc. (KPTI)

2mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Karyopharm Therapeutics Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Karyopharm Therapeutics Inc

7d ago, source: U.S. News & World Report

Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.

Karyopharm Therapeutics Inc (KPTI)

5d ago, source: Investing

View the KPTI option chain and compare options of Karyopharm Therapeutics Inc stock. Analyze the various options available, including call options (the right to buy) and put options (the right to ...